See the original post here:
NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to...
Author Archives: Fredricko
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial
Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos…
Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board
See the original post:
Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
See the original post here:
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting
Read the original here:
CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting
Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Read the original here:
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application
Agra Ventures Announces Results of its Annual General & Special Meeting
Read this article:
Agra Ventures Announces Results of its Annual General & Special Meeting